GE HealthCare Technologies Inc.
- Jurisdiction
United States - ISIN
US36266G1076 (GEHC )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€76.56 20.4% undervalued - Financial strength (Piotroski F-Value)
-
6
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
Profile
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. Read full profile
Fundamentals
- Net revenue
€17.03B - Gross margin
41.6% - EBIT
€2.35B - EBIT margin
13.8% - Net income
€1.91B - Net margin
11.2%
Statement period: - (published )
Estimates
| Fiscal Year | Net revenue | Net income |
|---|---|---|
|
|
| |
|
|
| |
|
|
|
Stock price
Dividends
- Last dividend amount
-
$0.04 - Ex date
-
- Payment date
-
- Dividend payout ratio
-
2.6%
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Congress transactions
| Name | Transaction date | Value |
|---|---|---|
| Austin Scott | August 13, 2025 | $1.00K–$15.00K |
| Robert Bresnahan | May 31, 2025 | $1.00K–$15.00K |
| Robert Bresnahan | April 28, 2025 | $1.00K–$15.00K |
| Robert Bresnahan | March 27, 2025 | $1.00K–$15.00K |
Earnings Calls
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Peter Brown |
|
|
|
Buy |
| Ray Dalio |
|
|
|
Buy |
Earnings Calls
Latest earnings call: April 30, 2024 (Q1 2024)